Headaches -- they affect us all. But when the problem is recurrent enough to drive your patient to tell you about it, there are a variety of effective management options. Accurate diagnosis is key. Help here.
The sphenopalatine ganglion (SPG) has recently been the target of a novel treatment for patients with cluster headaches. A sham-controlled randomized study of an implantable stimulator of the SPG offers encouraging preliminary results.
Highlights from the International Headache Congress are presented by Stephen D. Silberstein, MD, professor of neurology at Jefferson Medical College and director of the headache center at Thomas Jefferson University, Philadelphia, as well as chair of the congress organizing committee.